Last reviewed · How we verify
Bacteremia caused by Staphylococcus aureus
Approved treatments
- Cubicin · Baxter
Daptomycin is an antibacterial drug with lipopeptide structure. - Cubicin · Clinical Alliance for Research & Education - Infectious Diseases, LLC.
- DAPT · Baxter Hlthcare Corp
Dapt is a small molecule that works by interacting with specific biological targets, but the exact details of this interaction are unknown.
Competitive intelligence
For the full treatment-landscape CI brief — marketed leaders side-by-side, pipeline by phase, recent regulatory actions, sponsor landscape:
- Bacteremia caused by Staphylococcus aureus patent landscape — cliff calendar, originator estates, attackable patents
- Bacteremia caused by Staphylococcus aureus treatment landscape brief
- Bacteremia caused by Staphylococcus aureus treatment updates RSS
Frequently asked questions about Bacteremia caused by Staphylococcus aureus
What drugs treat Bacteremia caused by Staphylococcus aureus?
Tracked treatments include Cubicin, DAPT.
What is the treatment for Bacteremia caused by Staphylococcus aureus?
Standard treatment for Bacteremia caused by Staphylococcus aureus includes Cubicin, DAPT. See the treatment landscape page for first-line, second-line and salvage options.
Related
- Treatment landscape: Bacteremia caused by Staphylococcus aureus patent cliff · Bacteremia caused by Staphylococcus aureus CI report
- Treatment: Cubicin · Baxter
- Treatment: Cubicin · Clinical Alliance for Research & Education - Infectious Diseases, LLC.
- Treatment: DAPT · Baxter Hlthcare Corp
- All diseases: Browse the disease index · Disease landscape hub
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing